Business Description
Perspective Therapeutics is a US-based oncology company focused on developing targeted alpha therapies that deliver radiation directly to cancer cells with high precision. Its pipeline includes treatments for neuroendocrine tumors, metastatic melanoma, and prostate cancer, with several candidates currently in clinical trials. The company also has a research collaboration with Bristol Myers Squibb exploring combination therapy approaches for melanoma patients. Founded in 2004 and headquartered in Seattle, Washington, it was previously known as Isoray Inc. before rebranding in 2022.
